Search

everythinglearnresearchcommunity

for

Search:↓

Drugs can change hair growth and this is important because it can upset people.

An infant developed excessive hair growth after a bone marrow transplant and cyclosporine treatment.

Alopecia areata may be linked to kidney issues, but more research is needed.

Early diagnosis of GLPLS is crucial to prevent complications, but scarring alopecia is irreversible.

The dog had sebaceous adenitis, treated with ciclosporin, leading to some hair regrowth.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Switching immunosuppressants can improve hair regrowth and well-being in transplant patients experiencing hair loss.

Switching immunosuppressive drugs can improve hair regrowth and well-being in transplant patients with hair loss.

Hair loss from immunosuppressive drugs in transplant patients can affect well-being and treatment adherence, so personalized management is important.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

Red ink tattoos can cause severe skin reactions and complications, especially in those with autoimmune tendencies.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Infliximab can cause SAPHO syndrome, which may improve with Spesolimab and methotrexate.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Individualized treatment and psychological support improved the patient's quality of life and appearance despite medication side effects.

Early diagnosis and surgery are crucial for managing cryptorchidism and related hair loss in dogs.

Early diagnosis and personalized treatment can lead to significant hair regrowth in children with alopecia areata.

Janus kinase inhibitors are the most supported treatment for pediatric alopecia areata, while other options have limited evidence.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Timely and aggressive treatment is crucial for improving outcomes in severe complications of adult-onset Still's disease.

Systemic treatments like hydroxychloroquine and cyclosporine A help with Lichen Planopilaris and Frontal Fibrosing Alopecia, but ongoing treatment is needed.

Scalp psoriasis is treated with topical therapies, phototherapy, and systemic medications.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Early treatment is key for permanent hair loss disorders, with options ranging from medications and phototherapy to immunomodulators and antibiotics, depending on severity and type.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.